XVIVO — Xvivo Perfusion AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapFalling Star

Annual balance sheet for Xvivo Perfusion AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	Interim Report	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	354	399	246	546	415
Net Total Accounts Receivable
Net Total Receivables	43.7	63.9	104	139	141
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	463	548	468	826	813
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21.3	26.3	47.6	97.6	149
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,150	1,543	1,733	2,181	2,403
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	72.2	105	135	134	178
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	142	257	303	236	246
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,008	1,285	1,430	1,945	2,157
Total Liabilities & Shareholders' Equity	1,150	1,543	1,733	2,181	2,403
Total Common Shares Outstanding